⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
COLPAL - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.0
| Stock Code | COLPAL | Market Cap | 52,821 Cr. | Current Price | 1,942 ₹ | High / Low | 2,747 ₹ |
| Stock P/E | 39.6 | Book Value | 58.2 ₹ | Dividend Yield | 2.63 % | ROCE | 105 % |
| ROE | 81.2 % | Face Value | 1.00 ₹ | DMA 50 | 2,126 ₹ | DMA 200 | 2,256 ₹ |
| Chg in FII Hold | -1.98 % | Chg in DII Hold | 1.55 % | PAT Qtr | 330 Cr. | PAT Prev Qtr | 328 Cr. |
| RSI | 30.4 | MACD | -55.5 | Volume | 2,22,291 | Avg Vol 1Wk | 4,89,600 |
| Low price | 1,919 ₹ | High price | 2,747 ₹ | PEG Ratio | 3.95 | Debt to equity | 0.04 |
| 52w Index | 2.78 % | Qtr Profit Var | 2.25 % | EPS | 48.8 ₹ | Industry PE | 43.1 |
📊 Financial Overview
- Revenue & Profitability: Quarterly PAT remained stable (330 Cr. vs 328 Cr.), showing consistency. EPS at 48.8 ₹ is strong, reflecting solid earnings capacity.
- Margins & Returns: ROE at 81.2% and ROCE at 105% are exceptionally high, indicating outstanding efficiency and profitability.
- Debt Profile: Debt-to-equity ratio of 0.04 highlights a near debt-free balance sheet, ensuring stability.
- Cash Flow: Dividend yield of 2.63% provides strong shareholder returns, backed by consistent cash generation.
💹 Valuation Indicators
- P/E Ratio: 39.6 vs Industry PE of 43.1 → slightly undervalued relative to peers.
- P/B Ratio: Current Price 1,942 ₹ vs Book Value 58.2 ₹ → P/B ~33.4, very expensive compared to book value.
- PEG Ratio: 3.95 → suggests overvaluation relative to growth prospects.
- Intrinsic Value: Trading above intrinsic value, limiting near-term upside.
🏢 Business Model & Competitive Advantage
- Colgate-Palmolive India operates in oral care, personal care, and hygiene products, with strong brand recognition.
- Competitive advantage lies in market leadership, brand loyalty, and distribution strength.
- Debt-free structure and exceptional ROE/ROCE provide resilience and efficiency.
📈 Technical & Entry Zone
- Stock trading at 1,942 ₹, below 50 DMA (2,126 ₹) and 200 DMA (2,256 ₹), showing bearish momentum.
- RSI at 30.4 indicates oversold territory; MACD negative suggests short-term weakness.
- Entry Zone: Attractive between 1,900–1,950 ₹ for accumulation, with long-term holding potential.
✅ Positive
- Exceptional ROE (81.2%) and ROCE (105%).
- Debt-free balance sheet ensures financial stability.
- Strong dividend yield (2.63%) supports shareholder returns.
- Increase in DII holdings (+1.55%) signals domestic institutional confidence.
⚠️ Limitation
- P/B ratio (~33.4) indicates extreme premium valuation compared to book value.
- PEG ratio (3.95) suggests overvaluation relative to growth.
- FII holdings decreased (-1.98%), reflecting cautious foreign sentiment.
📉 Company Negative News
- No major recent negative news, but reduced FII holdings and high valuation raise caution.
📈 Company Positive News
- Stable quarterly PAT performance highlights operational consistency.
- Strong dividend yield and brand leadership reinforce long-term strength.
🏭 Industry
- FMCG sector benefits from steady demand in oral care and hygiene products.
- Industry PE at 43.1 indicates high valuations across the sector.
- Competition from domestic and global FMCG players remains a challenge.
🔮 Conclusion
- COLPAL shows strong fundamentals with exceptional efficiency, debt-free status, and consistent profitability.
- Valuation is stretched, limiting near-term upside, but long-term prospects remain positive due to brand strength and steady demand.
- Recommendation: Accumulate in the 1,900–1,950 ₹ range for long-term holding, focusing on dividend yield and FMCG sector resilience.